Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piera Merlini

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|March 17, 2009
The ischaemia/bleeding balance in PCIAlessandro Colombo, Piera Merlini
The American Journal of Cardiology|June 14, 2014
Eleven-year trends in gender differences of treatments and mortality in ST-elevation acute myocardial infarction in northern Italy, 2000 to 2010Elena Corrada, Giuseppe Ferrante, Cristina Mazzali, et al.
Circulation|April 14, 2010
Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36)Jessica L Mega, Judith S Hochman, Benjamin M Scirica, et al.
International Journal of Cardiology|November 27, 2025
Eligibility for Icosapent ethyl in patients undergoing cardiac rehabilitation: A real-world cohort studyFilippo Brucato, Chiara Tognola, Antonella Moreo, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|November 29, 2023
Secondary Prevention and Extreme Cardiovascular Risk Evaluation (SEVERE-1), Focus on Prevalence and Associated Risk Factors: The Study ProtocolAlessandro Maloberti, Rita Cristina Myriam Intravaia, Costantino Mancusi, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 18, 2026
Lipoprotein(a) Does Not Correlate with Hypertensive Mediated Organ Damage and Subsequent Cardiovascular Events in a Primary Prevention CohortChiara Tognola, Davide Paolo Bernasconi, Paola Rebora, et al.
American Journal of Preventive Cardiology|July 6, 2026
Inflammatory biomarkers relationship with major adverse cardiovascular events and hypertensive-mediated organ damage, in subjects without established cardiovascular diseaseChiara Tognola, Davide Paolo Bernasconi, Paola Rebora, et al.
Diabetologia|February 21, 2021
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitusMichelle L O'Donoghue, Eri T Kato, Ofri Mosenzon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|March 17, 2009
The ischaemia/bleeding balance in PCIAlessandro Colombo, Piera Merlini
The American Journal of Cardiology|June 14, 2014
Eleven-year trends in gender differences of treatments and mortality in ST-elevation acute myocardial infarction in northern Italy, 2000 to 2010Elena Corrada, Giuseppe Ferrante, Cristina Mazzali, et al.
Circulation|April 14, 2010
Clinical features and outcomes of women with unstable ischemic heart disease: observations from metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndromes-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36)Jessica L Mega, Judith S Hochman, Benjamin M Scirica, et al.
International Journal of Cardiology|November 27, 2025
Eligibility for Icosapent ethyl in patients undergoing cardiac rehabilitation: A real-world cohort studyFilippo Brucato, Chiara Tognola, Antonella Moreo, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|November 29, 2023
Secondary Prevention and Extreme Cardiovascular Risk Evaluation (SEVERE-1), Focus on Prevalence and Associated Risk Factors: The Study ProtocolAlessandro Maloberti, Rita Cristina Myriam Intravaia, Costantino Mancusi, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|March 18, 2026
Lipoprotein(a) Does Not Correlate with Hypertensive Mediated Organ Damage and Subsequent Cardiovascular Events in a Primary Prevention CohortChiara Tognola, Davide Paolo Bernasconi, Paola Rebora, et al.
American Journal of Preventive Cardiology|July 6, 2026
Inflammatory biomarkers relationship with major adverse cardiovascular events and hypertensive-mediated organ damage, in subjects without established cardiovascular diseaseChiara Tognola, Davide Paolo Bernasconi, Paola Rebora, et al.
Diabetologia|February 21, 2021
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitusMichelle L O'Donoghue, Eri T Kato, Ofri Mosenzon, et al.
Pageof 1